Sonoma Pharmaceuticals, Inc. SEC filings SNOA

Sonoma Pharmaceuticals, Inc. has 977 filings in SEC EDGAR's recent list, going back to Jan 15, 2002. Its latest annual report, Form 10-K, was filed on Jun 16, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on March 31.

Sonoma Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
8-A12B/A Amendment to form 8-a12b Oct 6, 2026 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Oct 6, 2026 Oct 6, 2026
8-K Current report
Shareholder vote results
Sep 17, 2026 Sep 16, 2026
8-K Current report
Shareholder vote results
Aug 19, 2026 Aug 19, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
DEF 14A Proxy statement Jul 28, 2026 Sep 16, 2026
DEFA14A Additional proxy material Jul 23, 2026 —
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
S-8 Employee stock plan registration Jul 9, 2026 —
DEFA14A Additional proxy material Jun 24, 2026 —
8-K Current report
Other events
Jun 18, 2026 Jun 18, 2026
424B5 Prospectus supplement Jun 18, 2026 —
10-K Annual report Jun 16, 2026 Mar 31, 2026
DEF 14A Proxy statement May 5, 2026 Jun 24, 2026
8-K Current report
Material agreement, Other events
Apr 30, 2026 Apr 24, 2026
424B4 Prospectus Apr 27, 2026 —
PRE 14A Preliminary proxy statement Apr 27, 2026 Apr 24, 2026
EFFECT Filing Apr 23, 2026 —
S-1/A Amended registration statement Apr 23, 2026 —
CORRESP Letter to the SEC Apr 22, 2026 —
CORRESP Letter to the SEC Apr 22, 2026 —
S-1 Registration statement Apr 17, 2026 —
UPLOAD Letter from the SEC Apr 10, 2026 —
DRS Filing Apr 9, 2026 —
8-K Current report
Material agreement
Apr 9, 2026 Apr 8, 2026
10-Q Quarterly report Feb 10, 2026 Dec 31, 2025
3 Initial insider ownership Feb 9, 2026 Jan 28, 2026
8-K Current report
Officer or director change
Jan 28, 2026 Jan 28, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
8-K Current report
Officer or director change
Jan 2, 2026 Jan 2, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Officer or director change
Oct 23, 2025 Oct 18, 2025
8-K Current report
Officer or director change
Oct 9, 2025 Oct 3, 2025
8-K Current report
Other events
Sep 29, 2025 Sep 29, 2025
8-K Current report
Material agreement
Sep 26, 2025 Sep 26, 2025
424B5 Prospectus supplement Sep 26, 2025 —
8-K Current report
Shareholder vote results
Aug 29, 2025 Aug 27, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
DEF 14A Proxy statement Jul 11, 2025 Aug 27, 2025
4 Insider transaction Jun 20, 2025 Jun 19, 2025
4 Insider transaction Jun 20, 2025 Jun 19, 2025
4 Insider transaction Jun 20, 2025 Jun 19, 2025
4 Insider transaction Jun 20, 2025 Jun 19, 2025
S-8 Employee stock plan registration Jun 17, 2025 —
10-K Annual report Jun 17, 2025 Mar 31, 2025
8-K Current report
Other events
Apr 28, 2025 Apr 28, 2025
8-K Current report
Other events
Apr 7, 2025 Apr 7, 2025
8-K Current report
Material agreement
Mar 25, 2025 Mar 21, 2025
10-Q Quarterly report Feb 5, 2025 Dec 31, 2024
8-K Current report
Material agreement
Jan 30, 2025 Jan 29, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
8-K Current report
Officer or director change
Jan 3, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 3, 2025 —
144/A Filing Jan 3, 2025 —
144/A Filing Jan 3, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Dec 26, 2024 —
S-8 Employee stock plan registration Dec 20, 2024 —
8-K Current report
Agreement ended
Nov 21, 2024 Nov 21, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Material agreement, Other events
Oct 22, 2024 Oct 17, 2024
8-K Current report
Other events
Sep 20, 2024 Sep 20, 2024
424B5 Prospectus supplement Sep 20, 2024 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Aug 28, 2024 Aug 23, 2024
8-K Current report
Other events
Aug 23, 2024 Aug 22, 2024
424B5 Prospectus supplement Aug 23, 2024 —
8-K Current report
Material agreement
Aug 21, 2024 Aug 19, 2024
DEFA14A Additional proxy material Aug 15, 2024 —
DEFA14A Additional proxy material Aug 15, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
DEFA14A Additional proxy material Jul 24, 2024 —
DEF 14A Proxy statement Jul 1, 2024 Aug 14, 2024
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
424B5 Prospectus supplement Jun 27, 2024 —
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 21, 2024 Jun 20, 2024
PRE 14A Preliminary proxy statement Jun 21, 2024 Aug 14, 2024
S-8 Employee stock plan registration Jun 17, 2024 —
10-K Annual report Jun 17, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
Apr 9, 2024 Apr 9, 2024
8-K Current report
Regulation FD disclosure
Apr 2, 2024 Apr 2, 2024
8-K Current report
Listing notice
Mar 22, 2024 Mar 21, 2024
8-K Current report
Material agreement
Mar 8, 2024 Mar 8, 2024
424B3 Prospectus Mar 8, 2024 —
10-Q Quarterly report Feb 8, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Jan 10, 2024 Jan 10, 2024
8-K Current report
Material agreement
Jan 9, 2024 Jan 5, 2024
4 Insider transaction Dec 29, 2023 Dec 29, 2023
4 Insider transaction Dec 29, 2023 Dec 29, 2023
4 Insider transaction Dec 29, 2023 Dec 29, 2023
4 Insider transaction Dec 29, 2023 Dec 29, 2023
8-K Current report
Officer or director change
Dec 29, 2023 Dec 29, 2023
8-K Current report
Material agreement
Dec 18, 2023 Dec 15, 2023
424B3 Prospectus Dec 15, 2023 —
424B5 Prospectus supplement Nov 22, 2023 —
EFFECT Filing Nov 20, 2023 —
CORRESP Letter to the SEC Nov 17, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
UPLOAD Letter from the SEC Nov 7, 2023 —
S-3 Shelf registration Nov 3, 2023 —
424B4 Prospectus Oct 30, 2023 —
EFFECT Filing Oct 26, 2023 —
CORRESP Letter to the SEC Oct 24, 2023 —
CORRESP Letter to the SEC Oct 24, 2023 —
CORRESP Letter to the SEC Oct 13, 2023 —
S-1/A Amended registration statement Oct 13, 2023 —
8-K/A Amended current report
Other events
Oct 11, 2023 Oct 11, 2023
8-K Current report
Regulation FD disclosure
Oct 11, 2023 Oct 11, 2023
8-K Current report
Listing notice, Shareholder vote results
Sep 28, 2023 Sep 22, 2023
UPLOAD Letter from the SEC Sep 27, 2023 —
S-1 Registration statement Sep 19, 2023 —
DEFA14A Additional proxy material Sep 15, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
DEF 14A Proxy statement Jul 27, 2023 Sep 14, 2023
3 Initial insider ownership Jul 21, 2023 Jul 17, 2023
8-K Current report
Officer or director change
Jul 14, 2023 Jul 11, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
4 Insider transaction Jul 3, 2023 Jun 30, 2023
10-K Annual report Jun 21, 2023 Mar 31, 2023
8-K Current report
Regulation FD disclosure
May 10, 2023 May 10, 2023
3 Initial insider ownership Apr 13, 2023 Apr 7, 2023
8-K Current report
Officer or director change
Apr 13, 2023 Apr 7, 2023
424B5 Prospectus supplement Feb 24, 2023 —
8-K Current report
Material agreement
Feb 24, 2023 Feb 24, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
8-K Current report
Material agreement
Jan 31, 2023 Jan 26, 2023
8-K Current report
Regulation FD disclosure
Jan 6, 2023 Jan 6, 2023
4 Insider transaction Dec 30, 2022 Dec 29, 2022
4 Insider transaction Dec 30, 2022 Dec 29, 2022
4 Insider transaction Dec 30, 2022 Dec 29, 2022
4 Insider transaction Dec 30, 2022 Dec 29, 2022
4 Insider transaction Dec 30, 2022 Dec 29, 2022
4 Insider transaction Dec 30, 2022 Dec 29, 2022
8-K Current report
Officer or director change
Dec 30, 2022 Dec 29, 2022
8-K Current report
Material agreement
Dec 23, 2022 Dec 23, 2022
424B3 Prospectus Dec 23, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
3 Initial insider ownership Oct 12, 2022 Oct 3, 2022
8-K Current report
Officer or director change
Oct 7, 2022 Oct 3, 2022
8-K Current report
Shareholder vote results
Sep 16, 2022 Sep 15, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
DEF 14A Proxy statement Jul 22, 2022 Sep 15, 2022
8-K Current report
Officer or director change
Jul 22, 2022 Jul 22, 2022
10-K Annual report Jul 13, 2022 Mar 31, 2022
NT 10-K Form 12b-25 Jun 29, 2022 Mar 31, 2022
10-Q Quarterly report Feb 11, 2022 Dec 31, 2021
8-K Current report
Material agreement
Jan 20, 2022 Jan 18, 2022
4 Insider transaction Jan 14, 2022 Jan 14, 2022
4 Insider transaction Jan 14, 2022 Jan 14, 2022
4 Insider transaction Jan 14, 2022 Jan 14, 2022
4 Insider transaction Jan 14, 2022 Jan 14, 2022
4 Insider transaction Jan 14, 2022 Jan 14, 2022
4 Insider transaction Jan 14, 2022 Jan 14, 2022
8-K Current report
Officer or director change
Jan 14, 2022 Jan 14, 2022
S-8 Employee stock plan registration Jan 13, 2022 —
8-K Current report
Regulation FD disclosure
Jan 6, 2022 Jan 6, 2022
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Material agreement
Nov 9, 2021 Nov 4, 2021
8-K Current report
Shareholder vote results, Other events
Sep 21, 2021 Sep 15, 2021
8-K Current report
Other events
Sep 3, 2021 Sep 3, 2021
424B3 Prospectus Sep 3, 2021 —
DEFA14A Additional proxy material Aug 30, 2021 —
DEFA14A Additional proxy material Aug 23, 2021 —
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
DEFA14A Additional proxy material Aug 16, 2021 —
8-K Current report
Officer or director change
Aug 2, 2021 Jul 27, 2021
8-K Current report
Material agreement
Jul 30, 2021 Jul 30, 2021
424B3 Prospectus Jul 30, 2021 —
DEF 14A Proxy statement Jul 29, 2021 Sep 15, 2021
8-K Current report
Auditor change
Jul 20, 2021 Jul 15, 2021
10-K Annual report Jul 14, 2021 Mar 31, 2021
8-K Current report
Auditor change
Jul 9, 2021 Jul 5, 2021
8-K Current report
Officer or director change
Jul 6, 2021 Jul 1, 2021
NT 10-K Notification of late filing Jun 29, 2021 Mar 31, 2021
8-K Current report
Material agreement
Mar 31, 2021 Mar 26, 2021
8-K Current report
Regulation FD disclosure
Mar 4, 2021 Mar 4, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
4 Insider transaction Jan 13, 2021 Jan 7, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
4 Insider transaction Jan 8, 2021 Jan 7, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SNOA (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Boulder, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1367083
Former names
Oculus Innovative Sciences, Inc. (until Dec 2, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.